Last updated on November 2017

Treatment Resistant Depression Study


Brief description of study

Treatment Resistant Depression Study

Detailed Study Description

A randomized, double-blind, active-controlled, multicenter study in male and female adult subjects with TRD to assess the efficacy, safety, and tolerability of flexibly dosed intranasal esketamine plus a newly initiated oral antidepressant compared with a newly initiated oral antidepressant plus intranasal placebo

Clinical Study Identifier: TX3466

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ashley Nalley

Atlanta Center for Medical Research
Atlanta, GA USA
  Connect »